Calmia Medical, Inc. is the developer and manufacturer of the Capillary Surfactometer.

This innovative system assists researchers in the study of pulmonary surfactant and its role in respiratory ailments such as Asthma, RDS (Respiratory Distress Syndrome), ARDS (Acute Respiratory Distress Syndrome), COPD (chronic obstructive pulmonary disease), Pneumonia and Cystic Fibrosis.

The Company markets its products globally to those investigating respiratory ailments and firms producing pharmaceuticals to treat pulmonary disease.


See video below for a demonstration of using the Capillary Surfactometer to measure Broncho-Alveolar Lavage Fluid (BALF) and how well the sample maintains open lung airways.